Singapore Creates Immunology Network To Coordinate Research
This article was originally published in PharmAsia News
The government of Singapore has established an immunology network to tie universities, hospitals and other institutions to a system of collaboration and coordination on the core subject of the country's initiative to foster biomedical science. Eventually, the network is to help create partnerships between local and international biotech and pharmaceutical companies. Those collaborations would focus on antibody platforms, immunotherapies for cancer, and development of vaccines and diagnostic for children. The research is to be divided into three areas, cancer immunology, immune disorders and immunity to infections. (Click here for more
You may also be interested in...
The approval is based on the results ABRE clinical study, which showed the stent improved patency iliofemoral veins in 88% of cases with a 2% rate of major adverse events.
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.